Delivery Order SPE2DB22D9239-SPE2DB24FDG15
Award Date 1/26/24
Potential Completion Date 2/16/24
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,088.88 contract will provide LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML medical supplies to support the recurring pharmaceutical needs of military health facilities under the DLA's Medical Supply Chain division. This delivery order is part of a larger $499,999,999 indefinite delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,861.10, is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period through May 29, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business based in Park Ridge, Illinois. The $15,444.40 contract is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product, by March 12, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with the DLA, valued up to $4,999,999 through 2025, to provide a wide range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the delivery of Lucentis 0.5 mg/0.05 ml syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,071.52 firm fixed-price delivery order is for LUCENTIS 0.3 MG/0.05 ML SYRING 0.05ML, with a performance period ending on August 23, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX24F5ZZU) valued at $11,583.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide Lucentis 0.5 mg/0.05 ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB), valued up to $499,999,999, that DMS Pharmaceutical Group holds with the DLA to supply a comprehensive range of pharmaceutical products to support the recurring medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,633.32 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Lucentis 0.5 mg/0.05 ml syringes, which are used to treat various medical conditions. The contract has an ultimate completion date of August 9, 2024 and does not have a set-aside designation. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a...
- This federal contract award is for LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $14,033.28 and an ultimate completion date of July 19, 2022. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,083.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lucentis 0.5 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,155.24 contract is for the supply of Lucentis 0.3 mg/0.05 ml syringes to fulfill the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...